Cite
HARVARD Citation
Lee, F. et al. (2016). Randomized Phase II Study of the X-linked Inhibitor of Apoptosis (XIAP) Antisense AEG35156 in Combination With Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC). American journal of clinical oncology. p. . [Online].